propofol has been researched along with Schizophrenia in 18 studies
Propofol: An intravenous anesthetic agent which has the advantage of a very rapid onset after infusion or bolus injection plus a very short recovery period of a couple of minutes. (From Smith and Reynard, Textbook of Pharmacology, 1992, 1st ed, p206). Propofol has been used as ANTICONVULSANTS and ANTIEMETICS.
propofol : A phenol resulting from the formal substitution of the hydrogen at the 2 position of 1,3-diisopropylbenzene by a hydroxy group.
Schizophrenia: A severe emotional disorder of psychotic depth characteristically marked by a retreat from reality with delusion formation, HALLUCINATIONS, emotional disharmony, and regressive behavior.
Excerpt | Relevance | Reference |
---|---|---|
"While propofol is known to shorten seizures during electroconvulsive therapy, in our previous study on patients with schizophrenia, there was no need for more frequent restimulations when using propofol compared with etomidate." | 9.12 | Comparison of propofol and etomidate regarding impact on seizure threshold during electroconvulsive therapy in patients with schizophrenia. ( Gábor, G; Judit, T; Zsolt, I, 2007) |
"We studied the changes in the bispectral index (BIS) of 22 patients during electroconvulsive therapy (ECT) under propofol and succinylcholine anesthesia." | 7.72 | [Bispectral index monitoring during anesthesia with propofol for electroconvulsive therapy]. ( Kazama, T; Nakai, T; Satoh, T; Umeda, E, 2004) |
"Propofol was found to reduce seizure duration to a significantly greater extent than etomidate." | 6.71 | Etomidate versus propofol for electroconvulsive therapy in patients with schizophrenia. ( Gazdag, G; Iványi, Z; Kocsis, N; Tolna, J, 2004) |
"Malignant catatonia (MC) is a movement disorder syndrome characterized by immobility, rigidity, and consciousness disorders that develops in association with mental and physical diseases." | 5.62 | Successful diagnosis and treatment of pulmonary aspergillosis-related malignant catatonia using propofol and quetiapine: A case report. ( Aisaka, W; Narimatsu, E; Nomura, K; Okamoto, H; Sakawaki, E; Sakawaki, S; Takeyama, Y; Uemura, S; Yamaoka, A, 2021) |
"Postictal delirium is an acute confusional state occurring during the immediate postictal phase in patients receiving electroconvulsive therapy that is characterized by motor agitation, disorientation, clouded consciousness, repetitive stereotyped movements, and poor response to commands." | 5.32 | Propofol in the management of postictal delirium with clozapine-electroconvulsive therapy combination. ( Bouckaert, F; Fernandez, I; Hagon, A; Hagon, B; Peuskens, J; Sienaert, P, 2004) |
"While propofol is known to shorten seizures during electroconvulsive therapy, in our previous study on patients with schizophrenia, there was no need for more frequent restimulations when using propofol compared with etomidate." | 5.12 | Comparison of propofol and etomidate regarding impact on seizure threshold during electroconvulsive therapy in patients with schizophrenia. ( Gábor, G; Judit, T; Zsolt, I, 2007) |
"Recorded files of patients from the two clinics were compared in terms of ECT indications, number and duration of seizures, and anesthetic agents used (propofol vs." | 3.79 | Comparing ECT data of two different inpatient clinics: propofol or thiopental? ( Bosgelmez, S; Karabulut, U; Kirpinar, I; Tas, HI; Yazici, AB; Yazici, E; Yildiz, M, 2013) |
"We studied the changes in the bispectral index (BIS) of 22 patients during electroconvulsive therapy (ECT) under propofol and succinylcholine anesthesia." | 3.72 | [Bispectral index monitoring during anesthesia with propofol for electroconvulsive therapy]. ( Kazama, T; Nakai, T; Satoh, T; Umeda, E, 2004) |
"Propofol was found to reduce seizure duration to a significantly greater extent than etomidate." | 2.71 | Etomidate versus propofol for electroconvulsive therapy in patients with schizophrenia. ( Gazdag, G; Iványi, Z; Kocsis, N; Tolna, J, 2004) |
"With methohexital, there was a clear postictal increase of mean blood pressure from 126/78 mm Hg to 161/102 mm Hg, whereas there was no increase with propofol (p = 0." | 2.69 | Propofol and methohexital as anesthetic agents for electroconvulsive therapy (ECT): a comparison of seizure-quality measures and vital signs. ( Geretsegger, C; Kartnig, C; Rochowanski, E; Unterrainer, AF, 1998) |
"Malignant catatonia (MC) is a movement disorder syndrome characterized by immobility, rigidity, and consciousness disorders that develops in association with mental and physical diseases." | 1.62 | Successful diagnosis and treatment of pulmonary aspergillosis-related malignant catatonia using propofol and quetiapine: A case report. ( Aisaka, W; Narimatsu, E; Nomura, K; Okamoto, H; Sakawaki, E; Sakawaki, S; Takeyama, Y; Uemura, S; Yamaoka, A, 2021) |
"Although mean motor seizure durations were significantly longer in groups R1 and R2 than in group P (P < 0." | 1.37 | Effect of divided supplementation of remifentanil on seizure duration and hemodynamic responses during electroconvulsive therapy under propofol anesthesia. ( Higuchi, M; Kawagishi, T; Nishikawa, K; Shimodate, Y; Yamakage, M, 2011) |
"The induction of a seizure is a core event in successful ECT." | 1.33 | Remifentanil supplementation of propofol during electroconvulsive therapy: effect on seizure duration and cardiovascular stability. ( Amiaz, R; Aronov, S; Etchin, A; Grunhaus, L; Vishne, T, 2005) |
"Postictal delirium is an acute confusional state occurring during the immediate postictal phase in patients receiving electroconvulsive therapy that is characterized by motor agitation, disorientation, clouded consciousness, repetitive stereotyped movements, and poor response to commands." | 1.32 | Propofol in the management of postictal delirium with clozapine-electroconvulsive therapy combination. ( Bouckaert, F; Fernandez, I; Hagon, A; Hagon, B; Peuskens, J; Sienaert, P, 2004) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (22.22) | 18.2507 |
2000's | 9 (50.00) | 29.6817 |
2010's | 4 (22.22) | 24.3611 |
2020's | 1 (5.56) | 2.80 |
Authors | Studies |
---|---|
Nomura, K | 1 |
Sakawaki, S | 1 |
Sakawaki, E | 1 |
Yamaoka, A | 1 |
Aisaka, W | 1 |
Okamoto, H | 1 |
Takeyama, Y | 1 |
Uemura, S | 1 |
Narimatsu, E | 1 |
Wojdacz, R | 1 |
Święcicki, Ł | 1 |
Antosik-Wójcińska, A | 1 |
Yazici, E | 1 |
Bosgelmez, S | 1 |
Tas, HI | 1 |
Karabulut, U | 1 |
Yazici, AB | 1 |
Yildiz, M | 1 |
Kirpinar, I | 1 |
Kikuchi, A | 1 |
Yasui-Furukori, N | 1 |
Fujii, A | 1 |
Katagai, H | 2 |
Kaneko, S | 1 |
Nishikawa, K | 1 |
Higuchi, M | 1 |
Kawagishi, T | 1 |
Shimodate, Y | 1 |
Yamakage, M | 1 |
Wang, N | 1 |
Wang, XH | 1 |
Lu, J | 1 |
Zhang, JY | 1 |
Kudoh, A | 2 |
Takase, H | 1 |
Takazawa, T | 1 |
Umeda, E | 1 |
Nakai, T | 1 |
Satoh, T | 1 |
Kazama, T | 1 |
Gazdag, G | 2 |
Kocsis, N | 1 |
Tolna, J | 2 |
Iványi, Z | 2 |
Sienaert, P | 1 |
Bouckaert, F | 1 |
Fernandez, I | 1 |
Hagon, A | 1 |
Hagon, B | 1 |
Peuskens, J | 1 |
Vishne, T | 1 |
Aronov, S | 1 |
Amiaz, R | 1 |
Etchin, A | 1 |
Grunhaus, L | 1 |
Gábor, G | 1 |
Judit, T | 1 |
Zsolt, I | 1 |
Sakaguchi, H | 1 |
Taguchi, H | 1 |
Ushijima, K | 1 |
Geretsegger, C | 1 |
Rochowanski, E | 1 |
Kartnig, C | 1 |
Unterrainer, AF | 1 |
Tanabe, T | 1 |
Sakai, T | 1 |
Mi, WD | 1 |
Matsuki, A | 1 |
Ishihara, H | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Inonu University, Turgut Ozal Medical Center, Department of Anesthesiology and Reanimation Malatya[NCT02271555] | Phase 4 | 58 participants (Anticipated) | Interventional | 2014-10-31 | Not yet recruiting | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
2 reviews available for propofol and Schizophrenia
Article | Year |
---|---|
Comparison of the effect of intravenous anesthetics used for anesthesia during electroconvulsive therapy on the hemodynamic safety and the course of ECT.
Topics: Anesthetics; Anesthetics, Intravenous; Autonomic Nervous System; Bipolar Disorder; Depressive Disord | 2017 |
[Applicability of intravenous anesthesia--special reference to propofol and ketamine].
Topics: Anesthesia, Intravenous; Anesthetics, Dissociative; Anesthetics, Inhalation; Anesthetics, Intravenou | 1999 |
5 trials available for propofol and Schizophrenia
Article | Year |
---|---|
The effect of repeated etomidate anesthesia on adrenocortical function during a course of electroconvulsive therapy.
Topics: Adrenal Cortex; Adrenocorticotropic Hormone; Adult; Anesthetics, Intravenous; Electroconvulsive Ther | 2011 |
Effect of preoperative discontinuation of antipsychotics in schizophrenic patients on outcome during and after anaesthesia.
Topics: Adult; Analysis of Variance; Anesthesia; Anesthesia Recovery Period; Anesthetics, Intravenous; Antip | 2004 |
Etomidate versus propofol for electroconvulsive therapy in patients with schizophrenia.
Topics: Adult; Anesthetics, Intravenous; Cross-Over Studies; Electroconvulsive Therapy; Etomidate; Female; H | 2004 |
Comparison of propofol and etomidate regarding impact on seizure threshold during electroconvulsive therapy in patients with schizophrenia.
Topics: Adult; Anesthetics, Intravenous; Electroconvulsive Therapy; Electroencephalography; Electromyography | 2007 |
Propofol and methohexital as anesthetic agents for electroconvulsive therapy (ECT): a comparison of seizure-quality measures and vital signs.
Topics: Adult; Anesthesia, Intravenous; Anesthetics, Intravenous; Blood Pressure; Carbon Dioxide; Cross-Over | 1998 |
11 other studies available for propofol and Schizophrenia
Article | Year |
---|---|
Successful diagnosis and treatment of pulmonary aspergillosis-related malignant catatonia using propofol and quetiapine: A case report.
Topics: Catatonia; Diagnosis, Differential; Female; Humans; Hypnotics and Sedatives; Middle Aged; Neurolepti | 2021 |
Comparing ECT data of two different inpatient clinics: propofol or thiopental?
Topics: Adult; Anesthesia, General; Anesthesia, Intravenous; Anesthetics, Intravenous; Bipolar Disorder; Bra | 2013 |
Identification of predictors of post-ictal delirium after electroconvulsive therapy.
Topics: Adult; Anesthesia, General; Catatonia; Delirium; Depressive Disorder, Major; Electroconvulsive Thera | 2009 |
Effect of divided supplementation of remifentanil on seizure duration and hemodynamic responses during electroconvulsive therapy under propofol anesthesia.
Topics: Adult; Aged; Anesthesia, Intravenous; Anesthetics, Intravenous; Depressive Disorder, Major; Dose-Res | 2011 |
Hypnosis first, then dissociation.
Topics: Anesthetics, Dissociative; Anesthetics, Intravenous; Delirium; Hallucinations; Humans; Hypnosis; Ket | 2003 |
[Bispectral index monitoring during anesthesia with propofol for electroconvulsive therapy].
Topics: Adult; Anesthesia; Anesthesia Recovery Period; Consciousness; Depression; Electroconvulsive Therapy; | 2004 |
Propofol in the management of postictal delirium with clozapine-electroconvulsive therapy combination.
Topics: Adult; Anesthetics, Intravenous; Antipsychotic Agents; Clozapine; Combined Modality Therapy; Deliriu | 2004 |
Remifentanil supplementation of propofol during electroconvulsive therapy: effect on seizure duration and cardiovascular stability.
Topics: Adult; Aged; Aged, 80 and over; Anesthetics, Intravenous; Depressive Disorder, Major; Electroconvuls | 2005 |
Impact of propofol and etomidate on seizure activity during electroconvulsive therapy in patients with schizophrenia.
Topics: Anesthetics, Intravenous; Electroencephalography; Electromyography; Etomidate; Humans; Propofol; Sch | 2007 |
[Propofol anesthesia for a schizophrenic patient].
Topics: Adult; Anesthesia, General; Anesthetics, Intravenous; Humans; Male; Perioperative Care; Propofol; Ps | 1997 |
[Electroconvulsive therapy decreased bispectral index--a case report].
Topics: Adult; Anesthesia, Intravenous; Anesthetics, Intravenous; Electroconvulsive Therapy; Electroencephal | 1998 |